Research Reports


Home » Reports » Anti Obesity Drugs Market Global Demand Analysis Opportunity Outlook 2021
Market Research Report

Anti Obesity Drugs Market : Global Demand Analysis & Opportunity Outlook 2021

Published On : 11:59 PM, 25th April, 2018 REP-ID-23 Category: Healthcare

Anti-obesity drugs are used to control body weight either by reducing appetite or absorption of calories. 
The global anti-obesity drug market is anticipated to grow at compound annual growth rate (CAGR) of 40.0 percent over the period of 2015-2020. Geographically, the global anti-obesity drug market is segmented into North America, Latin America, Western and Eastern Europe, Asia-Pacific and Rest of World.

Market Segmentation

By Product Type

Based on product type, the global anti-obesity drug market divided into two types:

  • Peripherally acting anti-obesity agents
  • Centrally acting anti-obesity drugs

By Type

  • Prescription Drugs
  • Over-the-Counter Drugs

By End User

Based on end user, the global anti-obesity drug market is segmented as:

  • Hospitals
  • Vendors

Growth Drivers and challenges

Prevailed bad eating habits, steep growth in packaged food consumption, less physical activity and hereditary concerns are the biggest factor in the increased obese people. Rising concern of health problems related to obesity, presence of large numbers of obese people around the globe and change in lifestyle are the major growth drivers of global anti-obesity drug market.

Global anti-obesity drug market faces some of major challenges like high cost involved in research and development, side effects of anti-obesity drugs, and rising popularities of other alternatives (fitness spas, therapies, etc.) to reduce obesity.

Market Size and Forecast

Regionally, North America anti-obesity drug market is forecasted to have a burgeoned growth during the forecast period i.e. 2015-2021. The market is likely to get propelled owing to rising cases of obesity, expanding healthcare industry and various government initiatives to curb obesity problems.

Europe anti-obesity drug market is also expected to witness a steady growth owing to rising cases of diabetes (which is majorly caused due to obesity) in some of the major European countries such as Germany, Spain, Italy, France and the U.K.

Asia-Pacific anti-obesity drug market is anticipated to bolster backed up by improvements in the healthcare sector and increase in disposable income. India and China are two major anti-obesity drug markets in Asia-Pacific region.

Key players

The major players of global anti-obesity drug market are mentioned as below:

  • Arena Pharmaceuticals Inc.,
  • F. Hoffmann-La Roche Ag,
  • GlaxoSmithKline plc,
  • Takeda Pharmaceuticals Company Limited,
  • Zafgen,
  • Zydus Cadila,
  • Rhythm Pharmaceuticals,
  • Pfizer Inc.,
  • Merck & Co. Inc.,
  • Orexigen Therapeutics Inc.,
  • Boehringer Ingelheim Gmbh
  • Eisai Co. Ltd.,
  • Novo Nordisk A/S,
  • Norgine B.V.

Scope and Context

Overview of the Parent Market

Analyst View

Market Size and Growth

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Western and Eastern Europe (Germany, Italy, Spain, France, U.K, Benelux, Hungary, Rest Of Western Europe, Russia Poland, Rest of Eastern Europe)
  • Asia-Pacific (China, India, Singapore, Japan, Australia & New Zealand & Rest of Asia)
  • Rest of World


  • By Product Type
  • By End User
  • By Region

Market Dynamics

Supply & Demand Risk

Competitive Landscape

Porter’s Five Force Model

Geographical Economic Activity

Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in current dynamic environment

Key Answers




    Direct access to analyst to help you understand the market in a better way to handle your critical question


    Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved


    Get 10% free customization


    Great focus on accuracy and quality of the research

Connect With Us

Call us

(U.S.) - +1 646 586 9123
(Canada) - +1 437 889 3230
(U.K.) - +44 203 608 5919
(India) - + 91 120 660 5495

Ask The Analyst

Delivery Center

Ansal Corporate Park, Plot no 7A/1,
Tower A1,
Sector 142 Noida., 201301 India

US Office

77 Water Street 8th Floor,
New York, New York, 10005
Phone : +1 646 586 9123

Canada (Toronto)

Phone : +1 437 889 3230

UK Office (London)

Phone : +44 203 608 5919

Copyright © 2018 Research Nester. All rights reserved